{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:40:04Z","timestamp":1793194804230,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012618"],"award-info":[{"award-number":["2023A1515012618"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160891"],"award-info":[{"award-number":["82160891"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174032"],"award-info":[{"award-number":["82174032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.biopha.2023.114957","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T16:38:18Z","timestamp":1686155898000},"page":"114957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Hepatoprotective effect of Typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1145-2347","authenticated-orcid":false,"given":"Yi","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liziniu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangpeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2023.114957_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12072-010-9202-6","article-title":"Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease","volume":"4","author":"Yang","year":"2010","journal-title":"Hepatol. Int."},{"issue":"7","key":"10.1016\/j.biopha.2023.114957_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072069","article-title":"Update on FXR biology: promising therapeutic target","volume":"19","author":"Han","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114957_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog. Lipid Res"},{"issue":"10","key":"10.1016\/j.biopha.2023.114957_bib4","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.biopha.2023.114957_bib5","doi-asserted-by":"crossref","first-page":"H272","DOI":"10.1152\/ajpheart.01075.2008","article-title":"Antiatherosclerotic effect of farnesoid X receptor","volume":"296","author":"Mencarelli","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"29","key":"10.1016\/j.biopha.2023.114957_bib6","doi-asserted-by":"crossref","first-page":"20799","DOI":"10.1074\/jbc.C700095200","article-title":"Catalytic activity is not required for secreted PCSK9 to reduce low density lipoprotein receptors in HepG2 cells","volume":"282","author":"McNutt","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2023.114957_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.plipres.2009.11.001","article-title":"Bile acid-activated receptors in the treatment of dyslipidemia and related disorders","volume":"49","author":"Fiorucci","year":"2010","journal-title":"Prog. Lipid Res"},{"issue":"1","key":"10.1016\/j.biopha.2023.114957_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2023.114957_bib9","article-title":"9 Bile acids acutely stimulate insulin secretion of mouse \u03b2-cells via farnesoid X receptor activation and K(ATP) channel inhibition.pdf","volume":"2012","author":"Martina D\u00fcfer","year":"2012","journal-title":"DIABETES"},{"key":"10.1016\/j.biopha.2023.114957_bib10","first-page":"147","article-title":"Glycogen synthase kinase-3 functions in oncogenesis and development","volume":"1114","author":"Simon","year":"1992","journal-title":"Biochim. Et. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.biopha.2023.114957_bib11","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1210\/en.2004-0965","article-title":"Regulation of carbohydrate metabolism by the farnesoid X receptor","volume":"146","author":"Stayrook","year":"2005","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.biopha.2023.114957_bib12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jep.2011.05.042","article-title":"Typha latifolia L. fruit polysaccharides induce the differentiation and stimulate the proliferation of human keratinocytes in vitro","volume":"137","author":"Gescher","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2023.114957_bib13","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1248\/cpb.36.4414","article-title":"Studies on the antihemmorhagic substances in herbs classified as hemostatics in Chinese medicine. IX. On the antihemmorhagic principles in Typha latifolia L","volume":"36","author":"Ishida","year":"1988","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.biopha.2023.114957_bib14","first-page":"441","article-title":"Studies on the constituents of the flavonoids from the pollen of Typha angustfolia L. (Puhuang)","volume":"21","author":"Jia","year":"1986","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.biopha.2023.114957_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120452","article-title":"Structure characterization of pectin from the pollen of Typha angustifolia L. and the inhibition activity of lipid accumulation in oleic acid induced L02 cells","volume":"303","author":"Xu","year":"2023","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.biopha.2023.114957_bib16","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1080\/13880209.2017.1300818","article-title":"Antioxidant capacity of Typha angustifolia extracts and two active flavonoids","volume":"55","author":"Chen","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2023.114957_bib17","unstructured":"W. D. S. G. W. Y, \"Effect of total flavonoid-containing serum of Phellodendron Bark on macrophage autophagy and Akt\/mTOR signaling pathway,\" The Journal of Practical Medicine, pp. 2017,33(16), 2017, doi: 10.3969\/j.issn.1006\u20435725.2017.16.012."},{"issue":"4","key":"10.1016\/j.biopha.2023.114957_bib18","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1074\/jbc.M209525200","article-title":"The farnesoid X-receptor is an essential regulator of cholesterol homeostasis","volume":"278","author":"Lambert","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114957_bib19","article-title":"21 Targeted disruption of the nuclear receptor FXR BAR impairs bile acid and lipid homeostasis.pdf","author":"Yang","year":"2010","journal-title":"Hepatol. Int."},{"issue":"4","key":"10.1016\/j.biopha.2023.114957_bib20","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI25604","article-title":"Farnesoid X receptor is essential for normal glucose homeostasis","volume":"116","author":"Ma","year":"2006","journal-title":"J. Clin. Invest"},{"issue":"19","key":"10.1016\/j.biopha.2023.114957_bib21","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1016\/j.febslet.2005.06.033","article-title":"Transient impairment of the adaptive response to fasting in FXR-deficient mice","volume":"579","author":"Cariou","year":"2005","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.biopha.2023.114957_bib22","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.biopha.2023.114957_bib23","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm1138","article-title":"Prevention of cholesterol gallstone disease by FXR agonists in a mouse model","volume":"10","author":"Moschetta","year":"2004","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.114957_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","article-title":"Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"48","author":"Musso","year":"2009","journal-title":"Prog. Lipid Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.114957_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106318","article-title":"Hepatic ZBTB22-mediated detoxification ameliorates acetaminophen-induced liver injury by inhibiting pregnane X receptor signaling (in eng)","volume":"26","author":"Chen","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2023.114957_bib26","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202256390","article-title":"Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1-driven gluconeogenesis (in eng)","author":"Liu","year":"2023","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2023.114957_bib27","article-title":"Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.biopha.2023.114957_bib28","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response (in eng)","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2023.114957_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/nm1185","article-title":"IKK beta links inflammation to obesity induced insulin resistance","author":"Arkan","year":"2005","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.114957_bib30","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J. Clin. Invest"},{"issue":"7","key":"10.1016\/j.biopha.2023.114957_bib31","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.4350","article-title":"Insulin action and resistance in obesity and type 2 diabetes","volume":"23","author":"Czech","year":"2017","journal-title":"Nat. Med"},{"issue":"11","key":"10.1016\/j.biopha.2023.114957_bib32","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.celrep.2016.05.019","article-title":"LSD1 interacts with Zfp516 to Promote UCP1 transcription and brown fat program","volume":"15","author":"Sambeat","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2023.114957_bib33","first-page":"8258","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Robson","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.biopha.2023.114957_bib34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","article-title":"A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis","volume":"92","author":"Puigserver","year":"1998","journal-title":"cell"},{"issue":"35","key":"10.1016\/j.biopha.2023.114957_bib35","doi-asserted-by":"crossref","first-page":"33370","DOI":"10.1074\/jbc.M305235200","article-title":"Acquirement of brown fat cell features by human white adipocytes","volume":"278","author":"Tiraby","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2023.114957_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcmgh.2022.04.011","article-title":"Hepatic SIRT6 modulates transcriptional activities of FXR to alleviate acetaminophen-induced hepatotoxicity","volume":"14","author":"Liu","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114957_bib37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1053\/jhep.2002.31724","article-title":"Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump","volume":"35","author":"Plass","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2023.114957_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2023.114957_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114340","article-title":"Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway","volume":"279","author":"Shen","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2023.114957_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7374086","article-title":"Chrysophanol alleviates metabolic syndrome by activating the SIRT6\/AMPK signaling pathway in brown adipocytes","volume":"2020","author":"Liu","year":"2020","journal-title":"Oxid. Med. Cell Longev."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223007473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223007473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:22:02Z","timestamp":1793193722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223007473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":40,"alternative-id":["S0753332223007473"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114957","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatoprotective effect of Typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114957"}}